- Research works
- 3 ▼ 52% vs 2013–17
- Citations
- 106 35.0 per fractional work
- Top-10% rate
- 100.0% record average 16.5%
- Open access
- 42% world 28%
Not ranked overall: AlzeCure Foundation is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Which research topics does AlzeCure Foundation publish most on?
By volume in 2022–2025: S100 Proteins and Annexins, Cerebrovascular and genetic disorders and Advanced Nanomaterials in Catalysis.
- 1 S100 Proteins and Annexins Molecular Biology 0 works
- 2 Cerebrovascular and genetic disorders Neurology 0 works
- 3 Advanced Nanomaterials in Catalysis Materials Chemistry 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has AlzeCure Foundation's research output changed?
Output in 2018–2022 was 52% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Huddinge
- Södertörn University
- Integrated Cardio Metabolic Centre
- Stockholm University College of Music Education
- Medivir (Sweden)
- Sprint Bioscience (Sweden)
- CellProtect Nordic Pharmaceuticals (Sweden)
- AlzeCure Pharma (Sweden)
- IMPETUS Afea (Sweden)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.